Medicare Enrolled
Dr. Harish Chandna, MD
Cardiovascular Disease · Victoria, TX
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chandna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chandna?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chandna
Dr. Harish Chandna is a cardiovascular disease specialist in Victoria, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chandna performed 5,244 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chandna received a total of $170,970 from 36 pharmaceutical and/or device companies across 466 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chandna is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 17% volume in TX
$170,970 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,244
Medicare services
Top 17% in TX for cardiovascular disease
Not available
Unique patients (not deduplicated)
$140
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,436 | $43 | $139 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
715 | $101 | $422 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
485 | $10 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
422 | $60 | $174 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
376 | $48 | $180 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 337 | $194 | $252 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
330 | $1,045 | $3,106 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
235 | $78 | $257 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
230 | $36 | $103 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
124 | $128 | $546 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
114 | $19 | $76 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
109 | $631 | $2,030 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
106 | $100 | $335 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
59 | $12 | $63 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
49 | $44 | $435 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. The procedure uses special cameras to create images of the heart's function. |
48 | $202 | $812 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
30 | $9 | $36 |
| Cardiac catheterization | 27 | $170 | $903 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
12 | $19 | $256 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
15.3% high complexity
45.3% medium
39.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$170,970
Total received (2018-2024)
Avg $24,424/year across 7 years
Top 3% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
466
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$798
2023
$4,543
2022
$14,117
2021
$12,162
2020
$22,772
2019
$69,524
2018
$47,054
Payments by company (2024)
Actelion Pharmaceuticals US, Inc.
$258
E.R. Squibb & Sons, L.L.C.
$147
Abbott Laboratories
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$103
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$45
Merck Sharp & Dohme LLC
$43
Edwards Lifesciences Corporation
$32
Lexicon Pharmaceuticals, Inc.
$15
Novartis Pharmaceuticals Corporation
$15
Novo Nordisk Inc
$14
Top 3 companies account for 66.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$128,366
Novartis Pharmaceuticals Corporation
$13,409
SANOFI-AVENTIS U.S. LLC
$11,543
PFIZER INC.
$11,508
E.R. Squibb & Sons, L.L.C.
$1,450
Abbott Laboratories
$837
Boehringer Ingelheim Pharmaceuticals, Inc.
$688
AstraZeneca Pharmaceuticals LP
$460
Merck Sharp & Dohme LLC
$420
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$303
Actelion Pharmaceuticals US, Inc.
$292
ABIOMED
$222
Amarin Pharma Inc.
$200
Amgen Inc.
$179
Merck Sharp & Dohme Corporation
$178
Boston Scientific Corporation
$147
Gilead Sciences, Inc.
$96
Relypsa, Inc.
$94
Regeneron Healthcare Solutions, Inc.
$84
Lundbeck LLC
$65
Allergan Inc.
$51
Chiesi USA, Inc.
$50
AltaThera Pharmaceuticals LLC
$45
BIOTRONIK INC.
$41
Regeneron Pharmaceuticals, Inc.
$35
Edwards Lifesciences Corporation
$32
Aziyo Biologics, Inc.
$25
MEDICOMP INC
$24
Esperion Therapeutics, Inc.
$18
ZOLL Circulation Inc
$17
Medtronic Vascular, Inc.
$17
Smith & Nephew, Inc.
$17
Astellas Pharma US Inc
$16
Lexicon Pharmaceuticals, Inc.
$15
Novo Nordisk Inc
$14
BOSTON SCIENTIFIC CORPORATION
$12
Top 3 companies account for 89.7% of all-time payments
Associated products mentioned in payments ›
Accent Pacemaker · Assurity Pacemaker · BOSENTAN TABLETS · BRILINTA · BYSTOLIC · Baerveldt Glaucoma Implants · CAMZYOS · CARDIOMEMS · CHANTIX · CLEVIPREX · Cardiac Monitor · CardioMEMS HF System · Connectivity and Remote care · Corlanor · DISEASE STATE · ECM · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · Ensite Cardiac Mapping System · Epclusa · FARXIGA · Fortify Assura · INVOKANA · Impella · JARDIANCE · KENGREAL · LEQVIO · Lexiscan · LifeVest · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · NEXLETOL · NORTHERA · OPSUMIT · PICO · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Assura CRT Defibrillator · RESONATE · Repatha · Resolute · Sotalol Hydrochloride · Temperature Management System · VERQUVO · VIGILANT · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
3
County median income
$70,101
Nearest hospital to ZIP centroid (approximate)
CITIZENS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chandna is a cardiac imaging specialist, with above-average Medicare volume (top 17% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chandna experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Chandna performed 1,436 regadenoson injection (lexiscan) for heart stress test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chandna receive payments from pharmaceutical companies?
Yes. Dr. Chandna received a total of $170,970 from 36 companies across 466 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chandna's costs compare to other cardiologists in Victoria?
Dr. Chandna's average Medicare payment per service is $140. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chandna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Victoria
Browse cardiologists in Victoria ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology